SBSPON

Model summary

A secreted extracellular matrix glycoprotein that uses an N-terminal somatomedin B module and a thrombospondin type-1 repeat to build a multivalent adhesion scaffold. By anchoring to matrix components and cell-surface receptors, it organizes local signaling environments that temper hemostatic pathways and favor balanced coagulation–fibrinolysis dynamics. Its disulfide-rich architecture and spondin-like C-terminus stabilize extracellular residency and avid protein binding, enabling it to modulate vascular and hemolysis processes within collagen-rich matrices.

Predicted Gene Ontology terms

1. 01

   I begin with the domain architecture.

   The N-terminal third contains IPR001212 (Somatomedin B domain, residues 24–75), which is encompassed by IPR036024 (Somatomedin B-like domain superfamily, residues 35–76). Somatomedin B (SB) modules are compact, disulfide-rich extracellular folds that mediate high-affinity protein–protein interactions and often anchor secreted matrix proteins to cell-surface receptors and protease systems. Immediately downstream lies a thrombospondin type-1 module: IPR044004 (Spondin-like TSP1 domain, residues 75–122) sits within IPR036383 (Thrombospondin type-1 repeat superfamily, residues 72–122) and is further supported by IPR000884 (Thrombospondin type-1 repeat, residues 74–133). TSP1 repeats are canonical extracellular adhesion/redistribution modules that bind glycosaminoglycans and cell-surface receptors, frequently shaping angiogenic and hemostatic cues. The C-terminal half is defined by IPR056801 (SBSPON-like, C-terminal, residues 148–257), a spondin-family tail that typically stabilizes matrix association and oligomerization. The entire polypeptide is captured by IPR039942 (Somatomedin-B and thrombospondin type-1 domain-containing protein family, residues 4–263), confirming a modular extracellular adhesion scaffold. The ordered layout—SB domain followed by a TSP1 repeat and a spondin-like C-terminus—creates a multivalent extracellular platform specialized for avid binding rather than catalysis.

2. 02

   This architecture dictates molecular function as protein binding (GO:0005515).

   The SB and TSP1 modules together generate high-avidity interfaces for extracellular matrix components, cell-surface receptors, and soluble mediators. The absence of catalytic motifs and the presence of multiple adhesive modules causally enforce a role as a binding hub that organizes and modulates extracellular signaling.

3. 03

   From this binding-centric function, the biological process emerges.

   TSP1 modules and SB domains are frequently deployed in vascular and hemostatic contexts; their multivalent matrix anchoring and receptor engagement enable suppression of procoagulant signaling and promotion of fibrinolytic balance. By sequestering or spatially modulating coagulation/hemolysis factors at the extracellular matrix, this scaffold can dampen thrombotic propagation, aligning with negative regulation of blood coagulation (GO:0030195). The spondin-like C-terminus further stabilizes matrix localization, reinforcing this anti-coagulation role through persistent extracellular residency.

4. 04

   Cellular location follows directly.

   The disulfide-rich SB and TSP1 modules are archetypal secreted extracellular folds, and the spondin-like tail supports matrix association. This composition necessitates secretion and extracellular matrix residency, placing the protein in the collagen-containing extracellular matrix (GO:0062023). The experimentally observed secreted status is mechanistically explained by the requirement for disulfide formation and extracellular folding of SB/TSP1 modules.

5. 05

   Mechanistically, I hypothesize that the protein assembles a matrix-tethered complex that binds glycosaminoglycans and cell-surface receptors to locally titrate coagulation and hemolysis pathways.

   Likely partners include integrins and heparan sulfate proteoglycans via the TSP1 repeat; vitronectin- and uPAR-like receptor systems via the SB domain; and matrix constituents such as collagens and fibronectin. By concentrating fibrinolytic and anticoagulant cues in defined extracellular niches, the scaffold attenuates thrombus formation and tunes vascular homeostasis.